Clare L Atzema1, Cynthia A Jackevicius2, Alice Chong2, Paul Dorian2, Noah M Ivers2, Ratika Parkash2, Peter C Austin2. 1. ICES Central (Atzema, Jackevicius, Chong, Ivers, Austin); Division of Emergency Medicine, Department of Medicine (Atzema), Division of Cardiology, Department of Medicine (Dorian), Department of Family Medicine (Ivers) and Institute for Health Policy, Management and Evaluation (Jackevicius, Dorian, Ivers, Austin), University of Toronto; Sunnybrook Health Sciences Centre (Atzema); Women's College Hospital (Ivers); St. Michael's Hospital (Dorian), Toronto, Ont.; Western University of Health Sciences, Pomona, Calif. (Jackevicius); QEII Health Sciences Centre (Parkash), Halifax, NS atzema@ices.on.ca. 2. ICES Central (Atzema, Jackevicius, Chong, Ivers, Austin); Division of Emergency Medicine, Department of Medicine (Atzema), Division of Cardiology, Department of Medicine (Dorian), Department of Family Medicine (Ivers) and Institute for Health Policy, Management and Evaluation (Jackevicius, Dorian, Ivers, Austin), University of Toronto; Sunnybrook Health Sciences Centre (Atzema); Women's College Hospital (Ivers); St. Michael's Hospital (Dorian), Toronto, Ont.; Western University of Health Sciences, Pomona, Calif. (Jackevicius); QEII Health Sciences Centre (Parkash), Halifax, NS.
Abstract
BACKGROUND: Patients with atrial fibrillation frequently seek emergency care. Rates of guideline-concordant oral anticoagulant therapy for stroke prevention are suboptimal in the community. We assessed the association between prescribing of oral anticoagulants in the emergency department (relative to referral to a longitudinal care provider for treatment initiation) and long-term use of oral anticoagulants. METHODS: This retrospective cohort study performed at 15 hospitals in Ontario, Canada, involved patients aged 65 years or older who visited the emergency department between 2009 and 2014, who had a primary diagnosis of atrial fibrillation, were discharged home, and were eligible for and willing to take stroke-prevention therapy. We used inverse probability-of-treatment weighting based on the propensity score to compare patients who were and were not given a prescription for an oral anticoagulant. The primary outcome was a prescription fill for an oral anticoagulant 6 months later. Secondary outcomes included a prescription fill at 1 year, all-cause mortality, and strokes or bleeding events leading to hospital admission. RESULTS: Of 2132 eligible patients, 402 (18.9%) were given a prescription for an oral anticoagulant in the emergency department. After weighting, 67.8% of these patients had filled a prescription for an oral anticoagulant at 6 months versus 37.2% of those who did not receive a prescription in the emergency department (absolute risk increase [ARI] 30.6%, number needed to treat [NNT] 3). At 1 year, the ARI was 23.2% and the NNT was 4. Rates of death, stroke and bleeding events did not differ significantly. INTERPRETATION: In patients with atrial fibrillation who were eligible for stroke prevention, prescribing an oral anticoagulant in the emergency department was associated with substantially higher long-term use of oral anticoagulants compared with deferring to the longitudinal care provider to initiate this therapy. Physicians working in the emergency department should consider initiating oral anticoagulation in eligible patients who are being discharged to home.
BACKGROUND:Patients with atrial fibrillation frequently seek emergency care. Rates of guideline-concordant oral anticoagulant therapy for stroke prevention are suboptimal in the community. We assessed the association between prescribing of oral anticoagulants in the emergency department (relative to referral to a longitudinal care provider for treatment initiation) and long-term use of oral anticoagulants. METHODS: This retrospective cohort study performed at 15 hospitals in Ontario, Canada, involved patients aged 65 years or older who visited the emergency department between 2009 and 2014, who had a primary diagnosis of atrial fibrillation, were discharged home, and were eligible for and willing to take stroke-prevention therapy. We used inverse probability-of-treatment weighting based on the propensity score to compare patients who were and were not given a prescription for an oral anticoagulant. The primary outcome was a prescription fill for an oral anticoagulant 6 months later. Secondary outcomes included a prescription fill at 1 year, all-cause mortality, and strokes or bleeding events leading to hospital admission. RESULTS: Of 2132 eligible patients, 402 (18.9%) were given a prescription for an oral anticoagulant in the emergency department. After weighting, 67.8% of these patients had filled a prescription for an oral anticoagulant at 6 months versus 37.2% of those who did not receive a prescription in the emergency department (absolute risk increase [ARI] 30.6%, number needed to treat [NNT] 3). At 1 year, the ARI was 23.2% and the NNT was 4. Rates of death, stroke and bleeding events did not differ significantly. INTERPRETATION: In patients with atrial fibrillation who were eligible for stroke prevention, prescribing an oral anticoagulant in the emergency department was associated with substantially higher long-term use of oral anticoagulants compared with deferring to the longitudinal care provider to initiate this therapy. Physicians working in the emergency department should consider initiating oral anticoagulation in eligible patients who are being discharged to home.
Authors: Atul Verma; John A Cairns; L Brent Mitchell; Laurent Macle; Ian G Stiell; David Gladstone; Michael Sean McMurtry; Stuart Connolly; Jafna L Cox; Paul Dorian; Noah Ivers; Kori Leblanc; Stanley Nattel; Jeff S Healey Journal: Can J Cardiol Date: 2014-08-13 Impact factor: 5.223
Authors: Laurent Macle; John Cairns; Kori Leblanc; Teresa Tsang; Allan Skanes; Jafna L Cox; Jeff S Healey; Alan Bell; Louise Pilote; Jason G Andrade; L Brent Mitchell; Clare Atzema; David Gladstone; Mike Sharma; Subodh Verma; Stuart Connolly; Paul Dorian; Ratika Parkash; Mario Talajic; Stanley Nattel; Atul Verma Journal: Can J Cardiol Date: 2016-09-06 Impact factor: 5.223
Authors: Karen Tu; Robby Nieuwlaat; Stephanie Y Cheng; Laura Wing; Noah Ivers; Clare L Atzema; Jeff S Healey; Paul Dorian Journal: Can J Cardiol Date: 2016-06-23 Impact factor: 5.223
Authors: Paraish Misra; Eddy Lang; Catherine M Clement; Robert J Brison; Brian H Rowe; Bjug Borgundvaag; Trevor Langhan; Kirk Magee; Rob Stenstrom; Jeffrey J Perry; David Birnie; George A Wells; X Xue; G Innes; Ian G Stiell Journal: J Atr Fibrillation Date: 2013-04-06
Authors: Cynthia A Jackevicius; Meytal Agvil Tsadok; Vidal Essebag; Clare Atzema; Mark J Eisenberg; Jack V Tu; Lingyun Lu; Elham Rahme; P Michael Ho; Mintu Turakhia; Karin H Humphries; Hassan Behlouli; Limei Zhou; Louise Pilote Journal: Heart Date: 2017-03-12 Impact factor: 5.994
Authors: Clare L Atzema; Peter C Austin; Eli Miller; Alice S Chong; Lingsong Yun; Paul Dorian Journal: Ann Emerg Med Date: 2013-06-27 Impact factor: 5.721
Authors: Jeff S Healey; Jonas Oldgren; Michael Ezekowitz; Jun Zhu; Prem Pais; Jia Wang; Patrick Commerford; Petr Jansky; Alvaro Avezum; Alben Sigamani; Albertino Damasceno; Paul Reilly; Alex Grinvalds; Juliet Nakamya; Akinyemi Aje; Wael Almahmeed; Andrew Moriarty; Lars Wallentin; Salim Yusuf; Stuart J Connolly Journal: Lancet Date: 2016-08-08 Impact factor: 79.321
Authors: Kim Schwab; Dacloc Nguyen; GilAnthony Ungab; Gregory Feld; Alan S Maisel; Martin Than; Laura Joyce; W Frank Peacock Journal: J Am Coll Emerg Physicians Open Date: 2021-08-09
Authors: Ian G Stiell; Kerstin de Wit; Frank X Scheuermeyer; Alain Vadeboncoeur; Paul Angaran; Debra Eagles; Ian D Graham; Clare L Atzema; Patrick M Archambault; Troy Tebbenham; Andrew D McRae; Warren J Cheung; Ratika Parkash; Marc W Deyell; Geneviève Baril; Rick Mann; Rupinder Sahsi; Suneel Upadhye; Erica Brown; Jennifer Brinkhurst; Christian Chabot; Allan Skanes Journal: CJEM Date: 2021-08-12 Impact factor: 2.410